StockData
Maze Therapeutics, Inc. logo

Maze Therapeutics, Inc. (MAZE) stock

MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$31.20−1.67 (-5.08%)

Close on Nov 18, 2026Market cap $1.73BP/E –Yield –

Maze Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Maze Therapeutics's profit margin for the twelve months ending Dec 31, 2024 was 31.2%. For fiscal 2024 it was 31.2%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202431.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-121.0%–
Q3 FY2024Sep 30, 2024-990.1%–
Q2 FY2024Jun 30, 202484.3%–

More Maze Therapeutics figures

See a number that looks wrong?